The University of Chicago Header Logo

Connection

Richard Schilsky to Drug Industry

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Drug Industry.
Richard Schilsky
Connection Strength
0.701
Drug Industry
  1. Reply to F.E. Vera-Badillo et al. J Clin Oncol. 2014 Oct 01; 32(28):3198.
    View in: PubMed
    Score: 0.475
  2. Rationale, Opportunities, and Reality of Biosimilar Medications. N Engl J Med. 2018 May 24; 378(21):2036-2044.
    View in: PubMed
    Score: 0.155
  3. Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tank. Am Heart J. 2024 Apr; 270:23-43.
    View in: PubMed
    Score: 0.057
  4. Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue. Clin Cancer Res. 2004 Jun 01; 10(11):3881-4.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.